Result of AGM

1

Adoption of Financial Statements

3,849,724,841

99.90

3,972,004

0.10

3,853,696,845

4,824,826

2

Approval of the Remuneration Report

3,506,794,850

92.88

268,917,463

7.12

3,775,712,313

82,829,542

3

Election of Simon Dingemans

3,848,384,170

99.88

4,592,054

0.12

3,852,976,224

5,550,786

4

Election of Ms Stacey Cartwright

3,841,823,906

99.71

11,062,363

0.29

3,852,886,269

5,643,742

5

Election of Ms Judy Lewent

3,843,559,263

99.75

9,499,395

0.25

3,853,058,658

5,471,278

6

Re-election of Sir Christopher Gent

3,736,569,130

96.97

116,649,598

3.03

3,853,218,728

5,314,008

7

Re-election of Andrew Witty

3,848,715,490

99.88

4,521,805

0.12

3,853,237,295

5,293,227

8

Re-election of Professor Sir Roy Anderson

3,849,621,453

99.91

3,645,550

0.09

3,853,267,003

5,262,933

9

Re-election of Dr Stephanie Burns

3,845,994,787

99.81

7,252,653

0.19

3,853,247,440

5,282,496

10

Re-election of Larry Culp

3,679,273,731

95.49

173,856,451

4.51

3,853,130,182

5,398,951

11

Re-election of Sir Crispin Davis

3,845,288,843

99.80

7,870,747

0.20

3,853,159,590

5,370,346

12

Re-election of Sir Deryck Maughan

3,618,533,477

93.91

234,597,016

6.09

3,853,130,493

5,409,443

13

Re-election of James Murdoch

3,749,042,808

97.30

103,982,301

2.70

3,853,025,109

5,504,826

14

Re-election of Dr Daniel Podolsky

3,849,525,259

99.91

3,602,607

0.09

3,853,127,866

5,402,070

15

Re-election of Dr Moncef Slaoui

3,848,000,866

99.87

5,004,470

0.13

3,853,005,336

5,225,725

16

Re-election of Tom de Swaan

3,767,791,974

97.78

85,429,903

2.22

3,853,221,877

5,318,058

17

Re-election of Sir Robert Wilson

3,849,258,200

99.90

4,000,688

0.10

3,853,258,888

5,270,983

18

Re-appointment of Auditors

3,772,864,832

99.32

25,647,503

0.68

3,798,512,335

60,025,660

19

Remuneration of Auditors

3,819,410,091

99.67

12,638,825

0.33

3,832,048,916

26,477,992

20

To authorise the company to make donations to political organisations and incur political expenditure

3,758,221,639

97.62

91,644,592

2.38

3,849,866,231

8,636,488

21

Authority to allot shares

3,781,033,581

98.16

70,843,798

1.84

3,851,877,379

6,624,572

22

Disapplication of pre-emption rights***

3,811,196,075

99.00

38,468,694

1.00

3,849,664,769

8,832,253

23

Authority for the Company to purchase its own shares***

3,786,160,872

98.25

67,324,020

1.75

3,853,484,892

5,049,760

24

Exemption from statement of senior statutory auditor's name

3,829,887,610

99.49

19,439,945

0.51

3,849,327,555

9,159,773

25

Reduced notice of a general meeting other than an AGM***

3,549,744,749

92.16

301,776,965

7.84

3,851,521,714

7,016,010

GlaxoSmithKline's

Eleventh AGM

(2011)

GlaxoSmithKline's

Tenth AGM

(2010)

Issued share capital

(excluding Treasury Shares)

5,163,907,153

5,192,489,588

Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)

74.72%

70.24%

Total shareholder population

155,990

164,450

Total number of proxies lodged

9,886

11,148

% of shareholders who lodged proxies

6.34%

6.78%

Number of shareholders, corporate representatives and proxies who attended the AGM

364

325

GlaxoSmithKline Enquiries:

UK Media enquiries:

David Mawdsley

(020) 8047 5502

Claire Brough

(020) 8047 5502

Stephen Rea

(020) 8047 5502

Alexandra Harrison

(020) 8047 5502

David Daley

(020) 8047 5502

US Media enquiries:

Nancy Pekarek

(919) 483 2839

Mary Anne Rhyne

(919) 483 2839

Kevin Colgan

(919) 483 2839

Jennifer Armstrong

(919) 483 2839

European Analyst/Investor enquiries:

Sally Ferguson

(020) 8047 5543

Gary Davies

(020) 8047 5503

Ziba Shamsi

(020) 8047 3289

US Analyst/ Investor enquiries:

Tom Curry

(215) 751 5419

Jeff McLaughlin

(215) 751 4890